Your browser doesn't support javascript.
loading
A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers.
Chen, Yihong; Wen, Haicheng; Li, Yin; Han, Ying; Tan, Jun; Guo, Cao; Cai, Changjing; Liu, Ping; Peng, Yinghui; Liu, Yihan; Wang, Xinwen; Zeng, Shan; Feng, Ziyang; Shen, Hong.
Afiliação
  • Chen Y; Department of Oncology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Wen H; Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Li Y; Department of Oncology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Han Y; Department of Oncology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Tan J; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Guo C; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Cai C; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Liu P; Department of Oncology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Peng Y; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Liu Y; Department of Oncology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Wang X; Department of Oncology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Zeng S; Department of Oncology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Feng Z; Department of Oncology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
  • Shen H; Department of Oncology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Biol Proced Online ; 25(1): 16, 2023 Jun 03.
Article em En | MEDLINE | ID: mdl-37268895

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article